Thursday, January 20, 2011

VentriPoint Banks over $1.8 million


VentriPoint Diagnostics Ltd.
VPT - TSX Venture
Shares issued: ~79.4 million
Fully diluted: ~99.6 million

------------------------------------------------------------------------------

VentriPoint announced today that it has closed its private placement for total gross proceeds of $1,808,866. Bloom Burton & Co. Inc., of Toronto lead the raise and has acknowledged that institutions played a big part in the private placement.

As a result of the financing the company issued a total of 10.64 million units at a price of $0.17. Each unit consists of one common share and one half of one common share purchase warrant exercisable at $0.25 for 36 months from closing.

According to the news release, the net proceeds of the private placement will be used for: (i) expenditures with respect to product and service commercialization of the VentriPoint Medical System ("VMS"); (ii) expansion of VMS functionality, including applications for additional diagnoses and heart diseases; and (iii) for working capital.

To view the full news release, please click here.